11.08.2011 • News

Lanxess Posts €181 Million Q2 Net Income

Lanxess posted second quarter net income of €181 million or €2.17 per share, up from €131 million or €1.57 per share last year. EBITDA pre exceptionals in the second quarter rose 26% year-over-year to €339 million.

Sales grew to €2.24 billion from €1.83 billion in the prior-year quarter. Lanxess said it implemented price increases in all segments in order to fully pass on higher raw material costs. In addition, there was volume growth and positive portfolio effects from recent acquisitions, above all the EPDM rubber business DSM Elastomers. Sales grew despite negative currency effects at minus 7% mainly due to a weak U.S. dollar.

"Demand for our products remains strong and plants are running at very high capacity utilization rates," said CEO Axel Heitmann. "Against this background and the strong first half of the year, we are lifting our full-year earnings guidance."

EBITDA pre exceptionals is now expected to grow about 20% year-on-year compared to €918 million in 2010. Earlier, EBITDA pre exceptionals were expected to grow 10-15%.

 

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read